A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)

被引：0
作者：
Gross, Evan
Li, Mingjia
Yin, Ming
Orcutt, Delaney
Hussey, Duncan
Trott, Elliot
Kramer, Joel
Oliva, Kaylee
Gore, John
Schade, George
Lin, Daniel
Tykodi, Scott
Hall, Evan
Thompson, John
Parikh, Anish
Yang, Yuanquan
Collier, Katharine
Miah, Abdul
Mori-Vogt, Sherry
Hinkley, Megan
Mortazavi, Amir
Monk, Paul
Folefac, Edmund
Clinton, Steven
Psutka, Sarah
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-08
引用
收藏
页码：E255 / E255
页数：1
相关论文
共 50 条
[21]   Surgical safety of Cytoreductive Nephrectomy (CN) following pretreatment with Immune Checkpoint Inhibition (ICI) combination therapy in primary metastatic clear-cell Renal Carcinoma (mccRCC) [J].
Graafland, N. M. ;
Szabados, B. ;
Mumtaz, F. ;
Barod, R. ;
Nicol, D. ;
Tanabalan, C. ;
Boleti, E. ;
Powles, T. ;
Haanen, J. ;
Bex, A. .
EUROPEAN UROLOGY, 2021, 79 :S896-S896
[22]   THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY WITH IMMUNE CHECKPOINT INHIBITOR THERAPIES IN METASTATIC RENAL CELL CARCINOMA MURINE MODEL [J].
Park, Jee Soo ;
Lee, Myung Eun ;
Jang, Won Sik ;
Kim, Jongchan ;
Park, Se Mi ;
Ham, Won Sik .
JOURNAL OF UROLOGY, 2023, 209 :E496-E497
[23]   Association of circulating tumor cells (CTCs) with immune checkpoint inhibitor (ICI) responses in metastatic renal cell carcinoma (mRCC) [J].
Zhang, T. ;
Poellmann, M. ;
Park, S-J. ;
Bu, J. ;
Zhao, R. ;
Zhou, Q. ;
Agarwal, A. ;
Parks, J. ;
Reyes-Martinez, M. ;
Armstrong, A. J. ;
George, D. J. ;
Wang, A. Z. ;
Hong, S. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S1221-S1221
[24]   SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR [J].
Lo, Jing Zhi ;
Sunaryo, Peter ;
Paulucci, David ;
Badani, Ketan .
JOURNAL OF UROLOGY, 2018, 199 (04) :E867-E867
[25]   Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma [J].
Ghoreifi, Alireza ;
Vaishampayan, Ulka ;
Yin, Ming ;
Psutka, Sarah P. ;
Djaladat, Hooman .
JAMA ONCOLOGY, 2024, 10 (02) :240-248
[26]   Long survival (SV) for metastatic renal cell cancer (mRCC) after cytoreductive nephrectomy (CN) plus lung metastasectomy (LM) without targeted therapy (TT) [J].
Corona-Cruz, Jose F. ;
Salvador, Miguel Patricio Moscoso-Fernandez ;
Ramirez-Tirado, Laura Alejandra ;
Gonzalez-Luna, Josue Andres ;
Alvarez, Miguel A. ;
Jimenez-Rios, Miguel Angel ;
Lopez Saucedo, Raul Alejandro ;
Jimenez-Fuentes, Edgardo ;
Arrieta Rodriguez, Oscar Gerardo .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[27]   Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy [J].
Richey, S. L. ;
Culp, S. H. ;
Jonasch, E. ;
Corn, P. G. ;
Pagliaro, L. C. ;
Tamboli, P. ;
Patel, K. K. ;
Matin, S. F. ;
Wood, C. G. ;
Tannir, N. M. .
ANNALS OF ONCOLOGY, 2011, 22 (05) :1048-1053
[28]   Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy [J].
Song Yan ;
Du ChunXia ;
Zhang Wen ;
Sun YongKun ;
Yang Lin ;
Cui ChengXu ;
Chi YiheBali ;
Shou JianZhong ;
Zhou AiPing ;
Li ChangLing ;
Ma JianHui ;
Wang JinWan ;
Sun Yan .
中华医学杂志英文版, 2016, 129 (05) :530-535
[29]   A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC) [J].
Elias, Roy ;
Levonyak, Nicholas ;
Christie, Alana ;
Bowman, Isaac Alexander ;
Kapur, Payal ;
Hannan, Raquibul ;
Hammers, Hans J. ;
Brugarolas, James .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[30]   Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy [J].
Song, Yan ;
Du, Chun-Xia ;
Zhang, Wen ;
Sun, Yong-Kun ;
Yang, Lin ;
Cui, Cheng-Xu ;
Chi, Yihe-Bali ;
Shou, Jian-Zhong ;
Zhou, Ai-Ping ;
Li, Chang-Ling ;
Ma, Jian-Hui ;
Wang, Jin-Wan ;
Sun, Yan .
CHINESE MEDICAL JOURNAL, 2016, 129 (05) :530-535
12345